Rank | Gene Set | Z-score |
---|---|---|
1 | aminoglycoside antibiotic metabolic process (GO:0030647) | 9.79351240 |
2 | drug transmembrane transport (GO:0006855) | 9.35351375 |
3 | urate metabolic process (GO:0046415) | 9.28001245 |
4 | drug transport (GO:0015893) | 7.88874619 |
5 | organic cation transport (GO:0015695) | 7.79908193 |
6 | phosphate ion transport (GO:0006817) | 7.39074521 |
7 | lysine catabolic process (GO:0006554) | 7.05081382 |
8 | lysine metabolic process (GO:0006553) | 7.05081382 |
9 | phosphate ion transmembrane transport (GO:0035435) | 5.97039004 |
10 | quaternary ammonium group transport (GO:0015697) | 5.93314936 |
11 | excretion (GO:0007588) | 5.77294586 |
12 | metanephric nephron tubule development (GO:0072234) | 5.73426423 |
13 | metanephric tubule development (GO:0072170) | 5.73426423 |
14 | response to mercury ion (GO:0046689) | 5.56559882 |
15 | drug catabolic process (GO:0042737) | 5.46626184 |
16 | glyoxylate metabolic process (GO:0046487) | 5.39182990 |
17 | tricarboxylic acid metabolic process (GO:0072350) | 5.32429529 |
18 | toxin transport (GO:1901998) | 5.27910467 |
19 | exogenous drug catabolic process (GO:0042738) | 5.24563117 |
20 | metanephric nephron epithelium development (GO:0072243) | 5.24519955 |
21 | nonribosomal peptide biosynthetic process (GO:0019184) | 5.17166678 |
22 | renal absorption (GO:0070293) | 5.13725419 |
23 | short-chain fatty acid metabolic process (GO:0046459) | 5.03907162 |
24 | cysteine metabolic process (GO:0006534) | 5.03137258 |
25 | vitamin D metabolic process (GO:0042359) | 4.95982504 |
26 | metanephric epithelium development (GO:0072207) | 4.86489034 |
27 | synaptic vesicle maturation (GO:0016188) | 4.85778456 |
28 | trivalent inorganic anion homeostasis (GO:0072506) | 4.81233933 |
29 | phosphate ion homeostasis (GO:0055062) | 4.81233933 |
30 | branched-chain amino acid metabolic process (GO:0009081) | 4.76423726 |
31 | glycoside metabolic process (GO:0016137) | 4.68439343 |
32 | aspartate family amino acid catabolic process (GO:0009068) | 4.67077655 |
33 | nephron tubule development (GO:0072080) | 4.56891934 |
34 | glutathione biosynthetic process (GO:0006750) | 4.46797279 |
35 | glutamate secretion (GO:0014047) | 4.41623443 |
36 | indole-containing compound catabolic process (GO:0042436) | 4.40146011 |
37 | indolalkylamine catabolic process (GO:0046218) | 4.40146011 |
38 | tryptophan catabolic process (GO:0006569) | 4.40146011 |
39 | homocysteine metabolic process (GO:0050667) | 4.36221273 |
40 | amino-acid betaine transport (GO:0015838) | 4.26604554 |
41 | carnitine transport (GO:0015879) | 4.26604554 |
42 | tryptophan metabolic process (GO:0006568) | 4.26306038 |
43 | aromatic amino acid family catabolic process (GO:0009074) | 4.24417843 |
44 | valine metabolic process (GO:0006573) | 4.19410207 |
45 | renal tubule development (GO:0061326) | 4.12274268 |
46 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.12238861 |
47 | synaptic vesicle exocytosis (GO:0016079) | 4.09688231 |
48 | modified amino acid transport (GO:0072337) | 4.08899617 |
49 | polyol transport (GO:0015791) | 4.08852701 |
50 | oligosaccharide catabolic process (GO:0009313) | 4.07802942 |
51 | 2-oxoglutarate metabolic process (GO:0006103) | 4.03779709 |
52 | peptide biosynthetic process (GO:0043043) | 4.01989590 |
53 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.00948126 |
54 | branched-chain amino acid catabolic process (GO:0009083) | 3.91476158 |
55 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.89959158 |
56 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.88143098 |
57 | L-phenylalanine catabolic process (GO:0006559) | 3.88143098 |
58 | proline metabolic process (GO:0006560) | 3.87488341 |
59 | neuron cell-cell adhesion (GO:0007158) | 3.85893057 |
60 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.80756540 |
61 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.79380645 |
62 | regulation of synaptic vesicle transport (GO:1902803) | 3.78811012 |
63 | nephron epithelium development (GO:0072009) | 3.78370425 |
64 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.77313599 |
65 | L-phenylalanine metabolic process (GO:0006558) | 3.77313599 |
66 | axonal fasciculation (GO:0007413) | 3.77011938 |
67 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.72976862 |
68 | cellular modified amino acid catabolic process (GO:0042219) | 3.68234351 |
69 | fatty acid beta-oxidation (GO:0006635) | 3.67982262 |
70 | regulation of synapse structural plasticity (GO:0051823) | 3.67407996 |
71 | cellular ketone body metabolic process (GO:0046950) | 3.65459313 |
72 | postsynaptic membrane organization (GO:0001941) | 3.65192884 |
73 | indole-containing compound metabolic process (GO:0042430) | 3.64412274 |
74 | response to phenylpropanoid (GO:0080184) | 3.60446299 |
75 | protein localization to synapse (GO:0035418) | 3.60374555 |
76 | peptide catabolic process (GO:0043171) | 3.58385834 |
77 | nephron tubule morphogenesis (GO:0072078) | 3.58176157 |
78 | nephron epithelium morphogenesis (GO:0072088) | 3.58176157 |
79 | fructose metabolic process (GO:0006000) | 3.55791599 |
80 | neuron recognition (GO:0008038) | 3.52533708 |
81 | vocalization behavior (GO:0071625) | 3.50160340 |
82 | amino-acid betaine metabolic process (GO:0006577) | 3.49482863 |
83 | serine family amino acid catabolic process (GO:0009071) | 3.47456586 |
84 | response to parathyroid hormone (GO:0071107) | 3.46557893 |
85 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.43892258 |
86 | sodium ion transport (GO:0006814) | 3.42646923 |
87 | fatty acid oxidation (GO:0019395) | 3.42541448 |
88 | neuronal ion channel clustering (GO:0045161) | 3.42013289 |
89 | lipid oxidation (GO:0034440) | 3.36456412 |
90 | acetyl-CoA metabolic process (GO:0006084) | 3.35770187 |
91 | indolalkylamine metabolic process (GO:0006586) | 3.32504957 |
92 | carnitine metabolic process (GO:0009437) | 3.26529961 |
93 | cellular response to vitamin D (GO:0071305) | 3.26045192 |
94 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.25658601 |
95 | beta-amyloid metabolic process (GO:0050435) | 3.24994027 |
96 | positive regulation of vesicle fusion (GO:0031340) | 3.24528490 |
97 | polyol catabolic process (GO:0046174) | 3.24040456 |
98 | presynaptic membrane assembly (GO:0097105) | 3.23061123 |
99 | glutamate metabolic process (GO:0006536) | 3.22033036 |
100 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.20804220 |
101 | sulfur compound transport (GO:0072348) | 3.19979206 |
102 | vitamin transport (GO:0051180) | 3.19388347 |
103 | serine family amino acid metabolic process (GO:0009069) | 3.17145683 |
104 | renal tubule morphogenesis (GO:0061333) | 3.15243783 |
105 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.14074702 |
106 | ketone body metabolic process (GO:1902224) | 3.12573727 |
107 | aromatic amino acid family metabolic process (GO:0009072) | 3.11539244 |
108 | kynurenine metabolic process (GO:0070189) | 3.11191743 |
109 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.09406582 |
110 | sodium-independent organic anion transport (GO:0043252) | 3.08682342 |
111 | positive regulation of mitochondrial fission (GO:0090141) | 3.05848323 |
112 | presynaptic membrane organization (GO:0097090) | 3.05447117 |
113 | cobalamin metabolic process (GO:0009235) | 3.04912640 |
114 | biotin metabolic process (GO:0006768) | 3.04394406 |
115 | neurotransmitter secretion (GO:0007269) | 3.03189125 |
116 | cellular potassium ion homeostasis (GO:0030007) | 3.02850833 |
117 | response to magnesium ion (GO:0032026) | 3.02148889 |
118 | establishment of mitochondrion localization (GO:0051654) | 3.01508032 |
119 | dopamine biosynthetic process (GO:0042416) | 3.01356941 |
120 | amine catabolic process (GO:0009310) | 3.01336669 |
121 | cellular biogenic amine catabolic process (GO:0042402) | 3.01336669 |
122 | nucleobase catabolic process (GO:0046113) | 3.01259791 |
123 | cell migration in hindbrain (GO:0021535) | 3.01194001 |
124 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.01004795 |
125 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 3.00298969 |
126 | regulation of vesicle fusion (GO:0031338) | 3.00286232 |
127 | fatty acid catabolic process (GO:0009062) | 2.99951974 |
128 | cellular amino acid catabolic process (GO:0009063) | 2.96389928 |
129 | response to growth hormone (GO:0060416) | 2.95989138 |
130 | auditory behavior (GO:0031223) | 2.95315978 |
131 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.94933668 |
132 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.93246275 |
133 | synapse assembly (GO:0007416) | 2.92290148 |
134 | synaptic transmission, glutamatergic (GO:0035249) | 2.90501450 |
135 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.90369660 |
136 | dendrite morphogenesis (GO:0048813) | 2.89481763 |
137 | fat-soluble vitamin catabolic process (GO:0042363) | 2.89251164 |
138 | vitamin catabolic process (GO:0009111) | 2.89251164 |
139 | axon extension (GO:0048675) | 2.88670475 |
140 | neurotransmitter biosynthetic process (GO:0042136) | 2.88643508 |
141 | alpha-amino acid catabolic process (GO:1901606) | 2.85017178 |
142 | sodium ion export (GO:0071436) | 2.78005833 |
143 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.75630451 |
144 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.74597588 |
145 | locomotory exploration behavior (GO:0035641) | 2.74162977 |
146 | neuron-neuron synaptic transmission (GO:0007270) | 2.73797618 |
147 | mating behavior (GO:0007617) | 2.71682187 |
148 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.67331883 |
149 | gamma-aminobutyric acid transport (GO:0015812) | 2.67310244 |
150 | layer formation in cerebral cortex (GO:0021819) | 2.66726667 |
151 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.66519995 |
152 | neuron projection extension (GO:1990138) | 2.62573515 |
153 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.59514309 |
154 | neurotransmitter transport (GO:0006836) | 2.57692587 |
155 | regulation of neurotransmitter levels (GO:0001505) | 2.56930778 |
156 | glutamate receptor signaling pathway (GO:0007215) | 2.56881887 |
157 | positive regulation of synapse assembly (GO:0051965) | 2.55111554 |
158 | dopamine transport (GO:0015872) | 2.51480222 |
159 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.50807835 |
160 | exploration behavior (GO:0035640) | 2.50347989 |
161 | detection of calcium ion (GO:0005513) | 2.50138468 |
162 | synaptic vesicle endocytosis (GO:0048488) | 2.50022256 |
163 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.49557029 |
164 | macroautophagy (GO:0016236) | 2.48826701 |
165 | synapse organization (GO:0050808) | 2.48766939 |
166 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.47255754 |
167 | mitochondrion transport along microtubule (GO:0047497) | 2.47255754 |
168 | regulation of dopamine secretion (GO:0014059) | 2.47131641 |
169 | cerebellar granule cell differentiation (GO:0021707) | 2.44545930 |
170 | dendritic spine organization (GO:0097061) | 2.43857824 |
171 | regulation of neurotransmitter secretion (GO:0046928) | 2.43492323 |
172 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.41895646 |
173 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.41771774 |
174 | activation of protein kinase A activity (GO:0034199) | 2.40079437 |
175 | negative regulation of neurotransmitter transport (GO:0051589) | 2.39837576 |
176 | regulation of neurotransmitter transport (GO:0051588) | 2.38149860 |
177 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.37555328 |
178 | response to manganese ion (GO:0010042) | 2.37136233 |
179 | organelle transport along microtubule (GO:0072384) | 2.36914542 |
180 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.36628042 |
181 | positive regulation of catecholamine secretion (GO:0033605) | 2.35403586 |
182 | adult walking behavior (GO:0007628) | 2.34490958 |
183 | long-term memory (GO:0007616) | 2.32852087 |
184 | response to auditory stimulus (GO:0010996) | 2.31150974 |
185 | suckling behavior (GO:0001967) | 2.27660927 |
186 | cell communication by electrical coupling (GO:0010644) | 2.27292077 |
187 | regulation of synapse assembly (GO:0051963) | 2.26511299 |
188 | neuronal action potential propagation (GO:0019227) | 2.26386603 |
189 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.26032383 |
190 | synaptic vesicle transport (GO:0048489) | 2.25966779 |
191 | establishment of synaptic vesicle localization (GO:0097480) | 2.25966779 |
192 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.25140911 |
193 | positive regulation of membrane potential (GO:0045838) | 2.23940502 |
194 | establishment of vesicle localization (GO:0051650) | 2.23699941 |
195 | glycosphingolipid biosynthetic process (GO:0006688) | 2.22843924 |
196 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.22304511 |
Rank | Gene Set | Z-score |
---|---|---|
1 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.50057227 |
2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.17990550 |
3 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.87697782 |
4 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.76159809 |
5 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.73832552 |
6 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.68462498 |
7 | VDR_22108803_ChIP-Seq_LS180_Human | 2.51344536 |
8 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.16546650 |
9 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 2.06725658 |
10 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.02172764 |
11 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.98240469 |
12 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.96172380 |
13 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.92089881 |
14 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.90561983 |
15 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.86876280 |
16 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.82049020 |
17 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.80789995 |
18 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.74874153 |
19 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.70586000 |
20 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.69689998 |
21 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.68741941 |
22 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.67215242 |
23 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.64444721 |
24 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.60256382 |
25 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.59636235 |
26 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.59636235 |
27 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.58195288 |
28 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.58056947 |
29 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.57268698 |
30 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.56691347 |
31 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.54707377 |
32 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.53763202 |
33 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.53598467 |
34 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.53129603 |
35 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.52546610 |
36 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.47976726 |
37 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.47851757 |
38 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.46134034 |
39 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.45359910 |
40 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.44911590 |
41 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.44738992 |
42 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.43548402 |
43 | P300_19829295_ChIP-Seq_ESCs_Human | 1.42508829 |
44 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.41126370 |
45 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.40580063 |
46 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.39185063 |
47 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.38326336 |
48 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.38280808 |
49 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.37783429 |
50 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.37064960 |
51 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.35361344 |
52 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.34405775 |
53 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.34337282 |
54 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.34081940 |
55 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.32393200 |
56 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.32212103 |
57 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.32195906 |
58 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.32145623 |
59 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.29999061 |
60 | FUS_26573619_Chip-Seq_HEK293_Human | 1.26730118 |
61 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.26647197 |
62 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.26538248 |
63 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.25190748 |
64 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.24516494 |
65 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.22793456 |
66 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.19866963 |
67 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.19598316 |
68 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.19324098 |
69 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.18862280 |
70 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.18723440 |
71 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.18708909 |
72 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.18563418 |
73 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.18531552 |
74 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.17935477 |
75 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.17650559 |
76 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.16542853 |
77 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.15850721 |
78 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.15630906 |
79 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.15061038 |
80 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.14196246 |
81 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.13905875 |
82 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.13641763 |
83 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.13443591 |
84 | RXR_22108803_ChIP-Seq_LS180_Human | 1.12916068 |
85 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.12570666 |
86 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.12332594 |
87 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.10871068 |
88 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.10330621 |
89 | KDM2B_26808549_Chip-Seq_REH_Human | 1.10130552 |
90 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.10093616 |
91 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.09879125 |
92 | AR_25329375_ChIP-Seq_VCAP_Human | 1.09775746 |
93 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.08360282 |
94 | * TP53_16413492_ChIP-PET_HCT116_Human | 1.08043567 |
95 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.07835158 |
96 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.07818565 |
97 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.07803299 |
98 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.06660603 |
99 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.06388481 |
100 | * LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05752747 |
101 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.04984973 |
102 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.04659996 |
103 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.04467248 |
104 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.04446875 |
105 | STAT3_23295773_ChIP-Seq_U87_Human | 1.03902667 |
106 | AR_19668381_ChIP-Seq_PC3_Human | 1.03869609 |
107 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.03390261 |
108 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.03112764 |
109 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.02711278 |
110 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.02392550 |
111 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.01876077 |
112 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.01066326 |
113 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.99591053 |
114 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.99439870 |
115 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.99273555 |
116 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.98943958 |
117 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.98745833 |
118 | JUN_21703547_ChIP-Seq_K562_Human | 0.98569438 |
119 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.98567393 |
120 | TCF4_23295773_ChIP-Seq_U87_Human | 0.98206578 |
121 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.98107129 |
122 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.98095668 |
123 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.98068729 |
124 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.97912528 |
125 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.97892372 |
126 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.97189612 |
127 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.97035810 |
128 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.96794524 |
129 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.96794524 |
130 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.96655275 |
131 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.96597924 |
132 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.94937652 |
133 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.94571735 |
134 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.94441034 |
135 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.94332317 |
136 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.94300941 |
137 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.93566685 |
138 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.91068878 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004043_abnormal_pH_regulation | 6.81141386 |
2 | MP0005360_urolithiasis | 6.49090268 |
3 | MP0003195_calcinosis | 4.83509328 |
4 | MP0004019_abnormal_vitamin_homeostasis | 4.61553234 |
5 | MP0005332_abnormal_amino_acid | 4.43416256 |
6 | MP0001765_abnormal_ion_homeostasis | 4.01829305 |
7 | MP0002138_abnormal_hepatobiliary_system | 3.67213334 |
8 | MP0009643_abnormal_urine_homeostasis | 3.66183131 |
9 | MP0004270_analgesia | 3.38936579 |
10 | MP0003880_abnormal_central_pattern | 3.22784087 |
11 | MP0002139_abnormal_hepatobiliary_system | 3.09658984 |
12 | MP0001756_abnormal_urination | 3.02744574 |
13 | MP0005636_abnormal_mineral_homeostasis | 2.90099846 |
14 | MP0005377_hearing/vestibular/ear_phenot | 2.89106279 |
15 | MP0003878_abnormal_ear_physiology | 2.89106279 |
16 | MP0002136_abnormal_kidney_physiology | 2.73638824 |
17 | MP0001984_abnormal_olfaction | 2.44734504 |
18 | MP0001958_emphysema | 2.39881092 |
19 | MP0002822_catalepsy | 2.22715871 |
20 | MP0006276_abnormal_autonomic_nervous | 2.21767122 |
21 | MP0008961_abnormal_basal_metabolism | 2.19440821 |
22 | MP0003329_amyloid_beta_deposits | 2.18731180 |
23 | MP0004885_abnormal_endolymph | 2.17228394 |
24 | MP0005423_abnormal_somatic_nervous | 2.11574555 |
25 | MP0003252_abnormal_bile_duct | 2.07950376 |
26 | MP0008875_abnormal_xenobiotic_pharmacok | 2.07137848 |
27 | MP0002572_abnormal_emotion/affect_behav | 1.97617257 |
28 | MP0000538_abnormal_urinary_bladder | 1.96749131 |
29 | MP0002272_abnormal_nervous_system | 1.88739887 |
30 | MP0002909_abnormal_adrenal_gland | 1.79871631 |
31 | MP0003283_abnormal_digestive_organ | 1.74837781 |
32 | MP0002734_abnormal_mechanical_nocicepti | 1.70524279 |
33 | MP0004272_abnormal_basement_membrane | 1.66874362 |
34 | MP0005058_abnormal_lysosome_morphology | 1.66506322 |
35 | MP0005248_abnormal_Harderian_gland | 1.63489058 |
36 | MP0005187_abnormal_penis_morphology | 1.61772820 |
37 | MP0002876_abnormal_thyroid_physiology | 1.60315980 |
38 | MP0001968_abnormal_touch/_nociception | 1.58841035 |
39 | MP0005171_absent_coat_pigmentation | 1.58828131 |
40 | MP0005365_abnormal_bile_salt | 1.56702462 |
41 | MP0005451_abnormal_body_composition | 1.52158763 |
42 | MP0000955_abnormal_spinal_cord | 1.51629997 |
43 | MP0001905_abnormal_dopamine_level | 1.51459501 |
44 | MP0000230_abnormal_systemic_arterial | 1.50455420 |
45 | MP0004811_abnormal_neuron_physiology | 1.45352193 |
46 | MP0003172_abnormal_lysosome_physiology | 1.45104783 |
47 | MP0005670_abnormal_white_adipose | 1.43931137 |
48 | MP0003632_abnormal_nervous_system | 1.42350890 |
49 | MP0002928_abnormal_bile_duct | 1.39923233 |
50 | MP0002168_other_aberrant_phenotype | 1.36682303 |
51 | MP0001299_abnormal_eye_distance/ | 1.36487291 |
52 | MP0002882_abnormal_neuron_morphology | 1.36291436 |
53 | MP0003631_nervous_system_phenotype | 1.34576195 |
54 | MP0001529_abnormal_vocalization | 1.34442835 |
55 | MP0001501_abnormal_sleep_pattern | 1.33993429 |
56 | MP0002638_abnormal_pupillary_reflex | 1.33542286 |
57 | MP0004924_abnormal_behavior | 1.32130542 |
58 | MP0005386_behavior/neurological_phenoty | 1.32130542 |
59 | MP0002557_abnormal_social/conspecific_i | 1.29885942 |
60 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.29052106 |
61 | MP0001661_extended_life_span | 1.27693543 |
62 | MP0000751_myopathy | 1.25616010 |
63 | MP0003690_abnormal_glial_cell | 1.25557381 |
64 | MP0005535_abnormal_body_temperature | 1.24104007 |
65 | MP0010386_abnormal_urinary_bladder | 1.20050461 |
66 | MP0001188_hyperpigmentation | 1.16550345 |
67 | MP0002653_abnormal_ependyma_morphology | 1.14677016 |
68 | MP0004742_abnormal_vestibular_system | 1.13111176 |
69 | MP0005084_abnormal_gallbladder_morpholo | 1.12663565 |
70 | MP0002184_abnormal_innervation | 1.12070081 |
71 | MP0004233_abnormal_muscle_weight | 1.11244216 |
72 | MP0005085_abnormal_gallbladder_physiolo | 1.10984285 |
73 | MP0003385_abnormal_body_wall | 1.10511143 |
74 | MP0010030_abnormal_orbit_morphology | 1.08332566 |
75 | MP0001177_atelectasis | 1.06484720 |
76 | MP0001970_abnormal_pain_threshold | 1.04795048 |
77 | MP0000516_abnormal_urinary_system | 1.04359623 |
78 | MP0005367_renal/urinary_system_phenotyp | 1.04359623 |
79 | MP0005623_abnormal_meninges_morphology | 1.02143629 |
80 | MP0002295_abnormal_pulmonary_circulatio | 1.01931915 |
81 | MP0002152_abnormal_brain_morphology | 1.01258827 |
82 | MP0000678_abnormal_parathyroid_gland | 0.99318356 |
83 | MP0000534_abnormal_ureter_morphology | 0.98435450 |
84 | MP0003122_maternal_imprinting | 0.98361125 |
85 | MP0003634_abnormal_glial_cell | 0.98188772 |
86 | MP0008438_abnormal_cutaneous_collagen | 0.97898004 |
87 | MP0002896_abnormal_bone_mineralization | 0.97821922 |
88 | MP0000604_amyloidosis | 0.96310590 |
89 | MP0002733_abnormal_thermal_nociception | 0.95504078 |
90 | MP0008569_lethality_at_weaning | 0.94751375 |
91 | MP0003183_abnormal_peptide_metabolism | 0.94105253 |
92 | MP0000749_muscle_degeneration | 0.94044287 |
93 | MP0002135_abnormal_kidney_morphology | 0.92834916 |
94 | MP0010368_abnormal_lymphatic_system | 0.92414340 |
95 | MP0005220_abnormal_exocrine_pancreas | 0.91530911 |
96 | MP0009780_abnormal_chondrocyte_physiolo | 0.91353983 |
97 | MP0002229_neurodegeneration | 0.91236942 |
98 | MP0003959_abnormal_lean_body | 0.90099733 |
99 | MP0003879_abnormal_hair_cell | 0.89000242 |
100 | MP0003300_gastrointestinal_ulcer | 0.88391027 |
101 | MP0001879_abnormal_lymphatic_vessel | 0.87736994 |
102 | MP0000013_abnormal_adipose_tissue | 0.84856377 |
103 | MP0000647_abnormal_sebaceous_gland | 0.84694580 |
104 | MP0004147_increased_porphyrin_level | 0.81785107 |
105 | MP0000537_abnormal_urethra_morphology | 0.81467039 |
106 | MP0009046_muscle_twitch | 0.80754635 |
107 | MP0005551_abnormal_eye_electrophysiolog | 0.80568190 |
108 | MP0001963_abnormal_hearing_physiology | 0.80326200 |
109 | MP0004085_abnormal_heartbeat | 0.80309338 |
110 | MP0005394_taste/olfaction_phenotype | 0.79771979 |
111 | MP0005499_abnormal_olfactory_system | 0.79771979 |
112 | MP0001485_abnormal_pinna_reflex | 0.79306214 |
113 | MP0004133_heterotaxia | 0.79276351 |
114 | MP0002752_abnormal_somatic_nervous | 0.78883456 |
115 | MP0002069_abnormal_eating/drinking_beha | 0.77899164 |
116 | MP0002067_abnormal_sensory_capabilities | 0.77285163 |
117 | MP0004145_abnormal_muscle_electrophysio | 0.77040827 |
118 | MP0005666_abnormal_adipose_tissue | 0.76211117 |
119 | MP0005645_abnormal_hypothalamus_physiol | 0.74046736 |
120 | MP0005167_abnormal_blood-brain_barrier | 0.73958194 |
121 | MP0003137_abnormal_impulse_conducting | 0.73635719 |
122 | MP0000569_abnormal_digit_pigmentation | 0.72247342 |
123 | MP0005319_abnormal_enzyme/_coenzyme | 0.71253221 |
124 | MP0001664_abnormal_digestion | 0.70743842 |
125 | MP0002233_abnormal_nose_morphology | 0.70728708 |
126 | MP0001764_abnormal_homeostasis | 0.70309838 |
127 | MP0001270_distended_abdomen | 0.70226832 |
128 | MP0003186_abnormal_redox_activity | 0.69898912 |
129 | MP0005503_abnormal_tendon_morphology | 0.69862122 |
130 | MP0001944_abnormal_pancreas_morphology | 0.69457096 |
131 | MP0001486_abnormal_startle_reflex | 0.69226781 |
132 | MP0002735_abnormal_chemical_nociception | 0.69071727 |
133 | MP0001346_abnormal_lacrimal_gland | 0.68085404 |
134 | MP0004858_abnormal_nervous_system | 0.68020629 |
135 | MP0000026_abnormal_inner_ear | 0.67890939 |
136 | MP0002064_seizures | 0.67317829 |
137 | MP0000750_abnormal_muscle_regeneration | 0.67287850 |
138 | MP0002089_abnormal_postnatal_growth/wei | 0.67195708 |
139 | MP0002078_abnormal_glucose_homeostasis | 0.66652469 |
140 | MP0003953_abnormal_hormone_level | 0.66417230 |
141 | MP0003938_abnormal_ear_development | 0.64709109 |
142 | MP0000371_diluted_coat_color | 0.64131151 |
143 | MP0009642_abnormal_blood_homeostasis | 0.63744141 |
144 | MP0002118_abnormal_lipid_homeostasis | 0.62693619 |
145 | MP0004264_abnormal_extraembryonic_tissu | 0.62367642 |
146 | MP0006036_abnormal_mitochondrial_physio | 0.62065561 |
147 | MP0003638_abnormal_response/metabolism_ | 0.59301587 |
148 | MP0009745_abnormal_behavioral_response | 0.57499971 |
149 | MP0005395_other_phenotype | 0.57211890 |
150 | MP0001666_abnormal_nutrient_absorption | 0.54535875 |
151 | MP0001502_abnormal_circadian_rhythm | 0.53408909 |
152 | MP0004859_abnormal_synaptic_plasticity | 0.50761761 |
153 | MP0002837_dystrophic_cardiac_calcinosis | 0.49744596 |
154 | MP0004484_altered_response_of | 0.49655296 |
155 | MP0005646_abnormal_pituitary_gland | 0.49642475 |
156 | MP0003635_abnormal_synaptic_transmissio | 0.49323278 |
157 | MP0000920_abnormal_myelination | 0.49049623 |
158 | MP0000778_abnormal_nervous_system | 0.47488952 |
159 | MP0000163_abnormal_cartilage_morphology | 0.47265089 |
160 | MP0000747_muscle_weakness | 0.47237947 |
161 | MP0002115_abnormal_skeleton_extremities | 0.46663952 |
162 | MP0002736_abnormal_nociception_after | 0.45099249 |
163 | MP0000631_abnormal_neuroendocrine_gland | 0.45055545 |
164 | MP0002998_abnormal_bone_remodeling | 0.44577003 |
165 | MP0003795_abnormal_bone_structure | 0.44271395 |
166 | MP0001440_abnormal_grooming_behavior | 0.43633336 |
167 | MP0003136_yellow_coat_color | 0.43476725 |
168 | MP0004142_abnormal_muscle_tone | 0.41962835 |
169 | MP0002066_abnormal_motor_capabilities/c | 0.41876172 |
170 | MP0005409_darkened_coat_color | 0.41640625 |
171 | MP0002063_abnormal_learning/memory/cond | 0.41378621 |
172 | MP0003633_abnormal_nervous_system | 0.40574825 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Increased circulating renin level (HP:0000848) | 8.28744075 |
2 | Metabolic alkalosis (HP:0200114) | 7.68977068 |
3 | Hypokalemic alkalosis (HP:0001949) | 7.41551898 |
4 | Hypomagnesemia (HP:0002917) | 7.41522921 |
5 | Hyperactive renin-angiotensin system (HP:0000841) | 7.02400949 |
6 | Polyuria (HP:0000103) | 6.75395084 |
7 | Abnormality of chloride homeostasis (HP:0011422) | 6.50551860 |
8 | Gout (HP:0001997) | 6.45581194 |
9 | Abnormal urine output (HP:0012590) | 6.27176243 |
10 | Abnormality of magnesium homeostasis (HP:0004921) | 6.13611665 |
11 | Abnormality of renal excretion (HP:0011036) | 5.90671074 |
12 | Abnormal drinking behavior (HP:0030082) | 5.63467679 |
13 | Polydipsia (HP:0001959) | 5.63467679 |
14 | Tetany (HP:0001281) | 5.41718407 |
15 | Abnormality of renin-angiotensin system (HP:0000847) | 5.23156890 |
16 | Proximal tubulopathy (HP:0000114) | 5.15272111 |
17 | Hyperaldosteronism (HP:0000859) | 5.02455236 |
18 | Limb dystonia (HP:0002451) | 4.88774550 |
19 | Increased purine levels (HP:0004368) | 4.73859674 |
20 | Hyperuricemia (HP:0002149) | 4.73859674 |
21 | Renal salt wasting (HP:0000127) | 4.73610897 |
22 | Alkalosis (HP:0001948) | 4.66963747 |
23 | Hypercalciuria (HP:0002150) | 4.21163608 |
24 | Hyperglycinuria (HP:0003108) | 4.19062282 |
25 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.16895973 |
26 | Generalized aminoaciduria (HP:0002909) | 4.04481741 |
27 | Hypokalemia (HP:0002900) | 4.03462397 |
28 | Abnormality of purine metabolism (HP:0004352) | 4.02477209 |
29 | Ketoacidosis (HP:0001993) | 3.93890784 |
30 | Myokymia (HP:0002411) | 3.65173575 |
31 | Renal tubular acidosis (HP:0001947) | 3.55042340 |
32 | Supranuclear gaze palsy (HP:0000605) | 3.49374486 |
33 | Action tremor (HP:0002345) | 3.47248131 |
34 | Abnormality of potassium homeostasis (HP:0011042) | 3.46715677 |
35 | Abnormality of the lower motor neuron (HP:0002366) | 3.46036334 |
36 | Abnormality of glycine metabolism (HP:0010895) | 3.40932496 |
37 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.40932496 |
38 | Focal motor seizures (HP:0011153) | 3.38954181 |
39 | Glycosuria (HP:0003076) | 3.36674060 |
40 | Abnormality of urine glucose concentration (HP:0011016) | 3.36674060 |
41 | Gait imbalance (HP:0002141) | 3.20680243 |
42 | Ketosis (HP:0001946) | 3.16617617 |
43 | Nephrocalcinosis (HP:0000121) | 3.10069401 |
44 | Focal seizures (HP:0007359) | 2.98884378 |
45 | Neurofibrillary tangles (HP:0002185) | 2.98701547 |
46 | Hyperphosphaturia (HP:0003109) | 2.93993935 |
47 | Abnormal urine phosphate concentration (HP:0012599) | 2.93961290 |
48 | Abnormality of nucleobase metabolism (HP:0010932) | 2.84596780 |
49 | Delayed epiphyseal ossification (HP:0002663) | 2.84232937 |
50 | Abnormality of proline metabolism (HP:0010907) | 2.83096609 |
51 | Hydroxyprolinuria (HP:0003080) | 2.83096609 |
52 | Drooling (HP:0002307) | 2.82929445 |
53 | Ankle clonus (HP:0011448) | 2.82725181 |
54 | Congenital primary aphakia (HP:0007707) | 2.80928752 |
55 | Postural instability (HP:0002172) | 2.77062744 |
56 | Hypophosphatemia (HP:0002148) | 2.76353546 |
57 | Nephrogenic diabetes insipidus (HP:0009806) | 2.70998951 |
58 | Febrile seizures (HP:0002373) | 2.68670709 |
59 | Widely patent fontanelles and sutures (HP:0004492) | 2.67141736 |
60 | Enlarged kidneys (HP:0000105) | 2.66344114 |
61 | Nephrolithiasis (HP:0000787) | 2.63733331 |
62 | Dysdiadochokinesis (HP:0002075) | 2.57754847 |
63 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.57187344 |
64 | Progressive cerebellar ataxia (HP:0002073) | 2.54200876 |
65 | Urinary urgency (HP:0000012) | 2.54080627 |
66 | Cerebral inclusion bodies (HP:0100314) | 2.53964816 |
67 | Truncal ataxia (HP:0002078) | 2.53262594 |
68 | Amyotrophic lateral sclerosis (HP:0007354) | 2.52974813 |
69 | Excessive salivation (HP:0003781) | 2.50185027 |
70 | Abnormality of the corticospinal tract (HP:0002492) | 2.50026943 |
71 | Atonic seizures (HP:0010819) | 2.47761369 |
72 | Vacuolated lymphocytes (HP:0001922) | 2.46194638 |
73 | Hypokinesia (HP:0002375) | 2.43086625 |
74 | Lower limb muscle weakness (HP:0007340) | 2.42504615 |
75 | Delayed CNS myelination (HP:0002188) | 2.39154840 |
76 | Decreased circulating renin level (HP:0003351) | 2.38338141 |
77 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.35350431 |
78 | Medial flaring of the eyebrow (HP:0010747) | 2.35230496 |
79 | Delayed gross motor development (HP:0002194) | 2.35145819 |
80 | Abnormality of sodium homeostasis (HP:0010931) | 2.34389698 |
81 | Dehydration (HP:0001944) | 2.33817644 |
82 | Renal tubular dysfunction (HP:0000124) | 2.33224589 |
83 | Absent speech (HP:0001344) | 2.32668133 |
84 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.32504091 |
85 | Hyperglycinemia (HP:0002154) | 2.31838337 |
86 | Confusion (HP:0001289) | 2.31554052 |
87 | Hyponatremia (HP:0002902) | 2.29809043 |
88 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.29760718 |
89 | Epileptic encephalopathy (HP:0200134) | 2.29302306 |
90 | Hand muscle atrophy (HP:0009130) | 2.29124750 |
91 | Rickets (HP:0002748) | 2.28254032 |
92 | Abnormality of renal resorption (HP:0011038) | 2.26797664 |
93 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.26519973 |
94 | Pheochromocytoma (HP:0002666) | 2.26497759 |
95 | Adrenal overactivity (HP:0002717) | 2.23865506 |
96 | Vaginal atresia (HP:0000148) | 2.22868152 |
97 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.22703645 |
98 | Spastic gait (HP:0002064) | 2.19133497 |
99 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.16859155 |
100 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.16859155 |
101 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.16300912 |
102 | Vascular calcification (HP:0004934) | 2.15503874 |
103 | Exotropia (HP:0000577) | 2.11439808 |
104 | Torticollis (HP:0000473) | 2.11214574 |
105 | Rapidly progressive (HP:0003678) | 2.10966507 |
106 | Scanning speech (HP:0002168) | 2.10430847 |
107 | Genital tract atresia (HP:0001827) | 2.10189444 |
108 | Bradykinesia (HP:0002067) | 2.09497873 |
109 | Broad-based gait (HP:0002136) | 2.09445756 |
110 | Insomnia (HP:0100785) | 2.08714583 |
111 | Poor coordination (HP:0002370) | 2.08119691 |
112 | Akinesia (HP:0002304) | 2.07576434 |
113 | Tubular atrophy (HP:0000092) | 2.06640441 |
114 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.04291004 |
115 | Metabolic acidosis (HP:0001942) | 2.02176370 |
116 | Intention tremor (HP:0002080) | 2.00917906 |
117 | Diminished movement (HP:0002374) | 2.00182079 |
118 | Dicarboxylic aciduria (HP:0003215) | 1.98675543 |
119 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.98675543 |
120 | Metaphyseal irregularity (HP:0003025) | 1.97301430 |
121 | Exercise-induced muscle cramps (HP:0003710) | 1.95915505 |
122 | Vomiting (HP:0002013) | 1.94180179 |
123 | Cutaneous finger syndactyly (HP:0010554) | 1.94048076 |
124 | Metaphyseal dysplasia (HP:0100255) | 1.92929288 |
125 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.92870303 |
126 | Hyperventilation (HP:0002883) | 1.92067873 |
127 | Hammertoe (HP:0001765) | 1.91037870 |
128 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.90930262 |
129 | Papillary thyroid carcinoma (HP:0002895) | 1.90717782 |
130 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.89804383 |
131 | Thin bony cortex (HP:0002753) | 1.89245764 |
132 | Cardiovascular calcification (HP:0011915) | 1.88221482 |
133 | Hyperkalemia (HP:0002153) | 1.88219512 |
134 | Dyskinesia (HP:0100660) | 1.86451113 |
135 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.85834453 |
136 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.85472315 |
137 | Aplasia of the phalanges of the hand (HP:0009802) | 1.84862628 |
138 | Aplasia involving bones of the extremities (HP:0009825) | 1.84862628 |
139 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.84862628 |
140 | Apathy (HP:0000741) | 1.84082525 |
141 | Diplopia (HP:0000651) | 1.83890871 |
142 | Abnormality of binocular vision (HP:0011514) | 1.83890871 |
143 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.83496420 |
144 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.83496420 |
145 | Metaphyseal cupping (HP:0003021) | 1.83018173 |
146 | Potter facies (HP:0002009) | 1.82402495 |
147 | Facial shape deformation (HP:0011334) | 1.82402495 |
148 | Abnormal eating behavior (HP:0100738) | 1.81834232 |
149 | Abnormality of the costochondral junction (HP:0000919) | 1.81417052 |
150 | Generalized tonic-clonic seizures (HP:0002069) | 1.80189493 |
151 | Gait ataxia (HP:0002066) | 1.80065328 |
152 | Methylmalonic aciduria (HP:0012120) | 1.79156644 |
153 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.79116169 |
154 | Specific learning disability (HP:0001328) | 1.78213947 |
155 | Hyperammonemia (HP:0001987) | 1.77522002 |
156 | Tubulointerstitial fibrosis (HP:0005576) | 1.75730323 |
157 | Bicornuate uterus (HP:0000813) | 1.75685625 |
158 | Open mouth (HP:0000194) | 1.75633240 |
159 | Rigidity (HP:0002063) | 1.75565015 |
160 | Hypotension (HP:0002615) | 1.73059721 |
161 | Hemiparesis (HP:0001269) | 1.72990082 |
162 | Dysmetria (HP:0001310) | 1.72847796 |
163 | Papilledema (HP:0001085) | 1.72547109 |
164 | Depression (HP:0000716) | 1.70364094 |
165 | Abnormality of the renal cortex (HP:0011035) | 1.69816742 |
166 | Cortical dysplasia (HP:0002539) | 1.69762238 |
167 | Polyphagia (HP:0002591) | 1.68707888 |
168 | Protruding tongue (HP:0010808) | 1.68445146 |
169 | Gaze-evoked nystagmus (HP:0000640) | 1.68033581 |
170 | Distal upper limb amyotrophy (HP:0007149) | 1.66291023 |
171 | Upper limb amyotrophy (HP:0009129) | 1.66291023 |
172 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.66157043 |
173 | Frequent falls (HP:0002359) | 1.65680438 |
174 | Hypoplasia of the iris (HP:0007676) | 1.64474082 |
175 | Neuronal loss in central nervous system (HP:0002529) | 1.64404342 |
176 | Peripheral hypomyelination (HP:0007182) | 1.64393769 |
177 | Broad foot (HP:0001769) | 1.64389838 |
178 | Tachypnea (HP:0002789) | 1.64087763 |
179 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.63401599 |
180 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.63401599 |
181 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.63401599 |
182 | Paraplegia (HP:0010550) | 1.63207918 |
183 | Spastic tetraplegia (HP:0002510) | 1.62386233 |
184 | Turricephaly (HP:0000262) | 1.62242133 |
185 | Enlarged epiphyses (HP:0010580) | 1.61330361 |
186 | Split foot (HP:0001839) | 1.60831620 |
187 | Abnormal tarsal ossification (HP:0008369) | 1.60766500 |
188 | Sensorimotor neuropathy (HP:0007141) | 1.60545844 |
189 | Elevated alkaline phosphatase (HP:0003155) | 1.60102015 |
190 | Flat cornea (HP:0007720) | 1.59956524 |
191 | Diminished motivation (HP:0000745) | 1.59467202 |
192 | Genetic anticipation (HP:0003743) | 1.58990257 |
193 | Dysostosis multiplex (HP:0000943) | 1.58700536 |
194 | Overriding aorta (HP:0002623) | 1.58235451 |
195 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.56936199 |
196 | Mucopolysacchariduria (HP:0008155) | 1.56936199 |
Rank | Gene Set | Z-score |
---|---|---|
1 | WNK3 | 8.53131244 |
2 | WNK4 | 7.98163690 |
3 | OXSR1 | 7.07317615 |
4 | STK39 | 3.90428400 |
5 | BCR | 2.15325222 |
6 | STK38L | 2.14283403 |
7 | WNK1 | 2.11018237 |
8 | CSNK1G2 | 2.07838251 |
9 | LATS2 | 2.04897391 |
10 | SGK494 | 2.00275471 |
11 | SGK223 | 2.00275471 |
12 | INSRR | 1.94131542 |
13 | BCKDK | 1.93514452 |
14 | CSNK1G3 | 1.67455769 |
15 | ERBB3 | 1.64893172 |
16 | DAPK2 | 1.47226432 |
17 | EPHB2 | 1.39827472 |
18 | AKT3 | 1.38029304 |
19 | SGK2 | 1.35782396 |
20 | PHKG1 | 1.26486866 |
21 | PHKG2 | 1.26486866 |
22 | MAPK15 | 1.26098134 |
23 | PDK4 | 1.18711141 |
24 | PDK3 | 1.18711141 |
25 | SIK2 | 1.16042475 |
26 | RIPK1 | 1.11278186 |
27 | SGK3 | 1.06967288 |
28 | LATS1 | 1.05739002 |
29 | NTRK3 | 1.03747303 |
30 | PKN2 | 1.03515686 |
31 | UHMK1 | 1.02964980 |
32 | STK38 | 1.02894066 |
33 | MAP4K2 | 1.01480904 |
34 | PINK1 | 1.00513686 |
35 | PDK2 | 0.97807863 |
36 | EPHA4 | 0.97494745 |
37 | MAPKAPK5 | 0.95851211 |
38 | PLK2 | 0.94008158 |
39 | CAMK2B | 0.93584724 |
40 | MARK2 | 0.91303827 |
41 | GRK5 | 0.89663594 |
42 | CAMK1G | 0.89604294 |
43 | SGK1 | 0.89424855 |
44 | CAMKK1 | 0.84817596 |
45 | CAMK2A | 0.83146923 |
46 | PDGFRA | 0.83109268 |
47 | RET | 0.82363811 |
48 | ARAF | 0.81929700 |
49 | CASK | 0.81751417 |
50 | CDK14 | 0.80455280 |
51 | TYRO3 | 0.78262363 |
52 | CAMK2G | 0.76543609 |
53 | PAK3 | 0.75842768 |
54 | CDK18 | 0.72648498 |
55 | MST1R | 0.71309763 |
56 | TNIK | 0.70995749 |
57 | TIE1 | 0.70661084 |
58 | DYRK1A | 0.69655903 |
59 | CDK15 | 0.69601838 |
60 | NEK1 | 0.67737044 |
61 | NEK6 | 0.67683703 |
62 | BRD4 | 0.67114993 |
63 | TESK1 | 0.66086355 |
64 | MAP3K4 | 0.61996249 |
65 | FER | 0.61392466 |
66 | MAP3K7 | 0.61208824 |
67 | GSK3A | 0.61027235 |
68 | MAP3K9 | 0.60179118 |
69 | MAP3K13 | 0.59354852 |
70 | CDK11A | 0.58992740 |
71 | EPHB1 | 0.58895629 |
72 | DYRK2 | 0.58495116 |
73 | PRKD2 | 0.58093833 |
74 | CAMK1D | 0.56498925 |
75 | OBSCN | 0.55410297 |
76 | PRKAA1 | 0.55311076 |
77 | IRAK1 | 0.55183044 |
78 | FGFR4 | 0.54794799 |
79 | CAMK1 | 0.54375839 |
80 | PRKAA2 | 0.53451037 |
81 | PIK3CG | 0.53013932 |
82 | MST4 | 0.52524219 |
83 | ROCK2 | 0.51147196 |
84 | IRAK2 | 0.50750922 |
85 | LIMK1 | 0.49813105 |
86 | CAMK2D | 0.49432106 |
87 | NTRK1 | 0.48666799 |
88 | MAPK10 | 0.48497770 |
89 | TGFBR2 | 0.47492088 |
90 | EPHA3 | 0.45621497 |
91 | PTK2 | 0.45559624 |
92 | PRKACB | 0.45410825 |
93 | FRK | 0.44164814 |
94 | MOS | 0.43764567 |
95 | PRKCE | 0.42736076 |
96 | GRK1 | 0.40783997 |
97 | PDGFRB | 0.40080608 |
98 | CSNK1D | 0.40074963 |
99 | MAP3K14 | 0.39544510 |
100 | DAPK1 | 0.38348323 |
101 | MAP3K5 | 0.38347619 |
102 | MAP2K7 | 0.37838153 |
103 | IRAK3 | 0.37742235 |
104 | RPS6KA3 | 0.37712774 |
105 | RIPK4 | 0.37201947 |
106 | PRKCH | 0.36432005 |
107 | GRK7 | 0.35953202 |
108 | BMPR2 | 0.32864923 |
109 | DYRK1B | 0.32423063 |
110 | PRKCZ | 0.31460468 |
111 | ADRBK2 | 0.31098568 |
112 | PRKCG | 0.30788144 |
113 | PDPK1 | 0.30156961 |
114 | PKN1 | 0.30106489 |
115 | STK11 | 0.29206572 |
116 | MET | 0.28312590 |
117 | PRKD3 | 0.27373369 |
118 | PRKACA | 0.26804456 |
119 | PNCK | 0.26285994 |
120 | PAK6 | 0.26079797 |
121 | MYLK | 0.25945704 |
122 | MINK1 | 0.24994594 |
123 | CDK5 | 0.23540862 |
124 | MAP2K4 | 0.23151188 |
125 | PRKACG | 0.23022547 |
126 | CAMKK2 | 0.22917938 |
127 | PRKCA | 0.22726389 |
128 | KSR1 | 0.21643709 |
129 | MAP3K12 | 0.21583984 |
130 | MAP3K2 | 0.21438990 |
131 | PTK6 | 0.21323746 |
132 | PDK1 | 0.21229159 |
133 | PRKCI | 0.21176006 |
134 | GRK6 | 0.21166822 |
135 | MAPK11 | 0.20318190 |
136 | CSNK1A1L | 0.18808336 |
137 | MARK1 | 0.18624420 |
138 | IGF1R | 0.18351528 |
139 | PRKCD | 0.18277056 |
140 | HIPK2 | 0.17693886 |
141 | CSNK1A1 | 0.17534291 |
142 | ERBB4 | 0.16681379 |
143 | MAPK13 | 0.16187799 |
144 | CDC42BPA | 0.15850458 |
145 | CAMK4 | 0.15711109 |
146 | CSNK1G1 | 0.15405086 |
147 | YES1 | 0.15400138 |
148 | PTK2B | 0.15341444 |
149 | NTRK2 | 0.15310674 |
150 | MAP3K6 | 0.14099900 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Butanoate metabolism_Homo sapiens_hsa00650 | 3.99004054 |
2 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.96448135 |
3 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 3.35681322 |
4 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.11032177 |
5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.09343965 |
6 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.01632994 |
7 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.74948208 |
8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.55824596 |
9 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.45495295 |
10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.40867131 |
11 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.38318613 |
12 | Peroxisome_Homo sapiens_hsa04146 | 2.34024886 |
13 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.32805671 |
14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.32035928 |
15 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.29596926 |
16 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.15234075 |
17 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.02012105 |
18 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.96956241 |
19 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.96779639 |
20 | Circadian entrainment_Homo sapiens_hsa04713 | 1.92656610 |
21 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.86779590 |
22 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.82714100 |
23 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.81930865 |
24 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.76042040 |
25 | Other glycan degradation_Homo sapiens_hsa00511 | 1.69693730 |
26 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.63093197 |
27 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.60951357 |
28 | Bile secretion_Homo sapiens_hsa04976 | 1.52877223 |
29 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.51821625 |
30 | Lysine degradation_Homo sapiens_hsa00310 | 1.49739735 |
31 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.48291548 |
32 | Long-term potentiation_Homo sapiens_hsa04720 | 1.42766456 |
33 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.40114448 |
34 | Axon guidance_Homo sapiens_hsa04360 | 1.37633096 |
35 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.36780238 |
36 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.36598330 |
37 | Mineral absorption_Homo sapiens_hsa04978 | 1.30211872 |
38 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.28981738 |
39 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.18324444 |
40 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.14386136 |
41 | Melanogenesis_Homo sapiens_hsa04916 | 1.09214425 |
42 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.08494167 |
43 | Carbon metabolism_Homo sapiens_hsa01200 | 1.06327288 |
44 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.03560580 |
45 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.01248056 |
46 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.01155848 |
47 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.00034241 |
48 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.99163454 |
49 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.98393808 |
50 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.97725605 |
51 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.97570720 |
52 | Gap junction_Homo sapiens_hsa04540 | 0.96630438 |
53 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.96531595 |
54 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.95284693 |
55 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.93421835 |
56 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.92914194 |
57 | Lysosome_Homo sapiens_hsa04142 | 0.91928465 |
58 | Histidine metabolism_Homo sapiens_hsa00340 | 0.86421041 |
59 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.85811641 |
60 | Long-term depression_Homo sapiens_hsa04730 | 0.84823318 |
61 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.84730664 |
62 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.84103390 |
63 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.82073730 |
64 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.81818107 |
65 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.81744986 |
66 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.81412993 |
67 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.79968234 |
68 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.79279752 |
69 | Olfactory transduction_Homo sapiens_hsa04740 | 0.78783961 |
70 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.76941891 |
71 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.76288182 |
72 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.75288924 |
73 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.74170674 |
74 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.74007219 |
75 | * Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.73385022 |
76 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.73045802 |
77 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.70799705 |
78 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.70593644 |
79 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.70343876 |
80 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.69385894 |
81 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.67182491 |
82 | Tight junction_Homo sapiens_hsa04530 | 0.67101945 |
83 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.66716983 |
84 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.65278479 |
85 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.63659421 |
86 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.63627506 |
87 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.61962343 |
88 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.61654139 |
89 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.60871302 |
90 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.59786915 |
91 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.59507887 |
92 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.58435119 |
93 | Glioma_Homo sapiens_hsa05214 | 0.57651297 |
94 | Insulin secretion_Homo sapiens_hsa04911 | 0.57313606 |
95 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.56917113 |
96 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.56730876 |
97 | Adherens junction_Homo sapiens_hsa04520 | 0.56433369 |
98 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.56298264 |
99 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.55894295 |
100 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.55790166 |
101 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.55306044 |
102 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.54911860 |
103 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.54615102 |
104 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.54549395 |
105 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.53934055 |
106 | Phototransduction_Homo sapiens_hsa04744 | 0.53350810 |
107 | Nicotine addiction_Homo sapiens_hsa05033 | 0.53245085 |
108 | Focal adhesion_Homo sapiens_hsa04510 | 0.52415684 |
109 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.51890259 |
110 | Prion diseases_Homo sapiens_hsa05020 | 0.51282556 |
111 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.50330278 |
112 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.50152410 |
113 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.49530131 |
114 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.49243065 |
115 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.48750501 |
116 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.48327996 |
117 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.47937947 |
118 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.47319183 |
119 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.46887164 |
120 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.46499897 |
121 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.46282537 |
122 | Endometrial cancer_Homo sapiens_hsa05213 | 0.44555456 |
123 | ABC transporters_Homo sapiens_hsa02010 | 0.43359399 |
124 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.43126143 |
125 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.42842658 |
126 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.41626420 |
127 | GABAergic synapse_Homo sapiens_hsa04727 | 0.41461409 |
128 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.40136402 |
129 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.39038464 |
130 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.38817536 |
131 | Taste transduction_Homo sapiens_hsa04742 | 0.37200702 |
132 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.37176041 |
133 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.33229891 |
134 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.33042766 |
135 | Retinol metabolism_Homo sapiens_hsa00830 | 0.31570908 |
136 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.31326997 |
137 | Morphine addiction_Homo sapiens_hsa05032 | 0.28870429 |
138 | Salivary secretion_Homo sapiens_hsa04970 | 0.26473716 |
139 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.26063667 |
140 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.24165058 |
141 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.22956665 |
142 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.22882309 |
143 | Renin secretion_Homo sapiens_hsa04924 | 0.21607889 |
144 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.20888230 |
145 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.20873812 |
146 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.19963831 |
147 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.19727946 |
148 | Parkinsons disease_Homo sapiens_hsa05012 | 0.17530183 |
149 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.17151601 |
150 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.15529883 |
151 | Circadian rhythm_Homo sapiens_hsa04710 | 0.15031704 |
152 | Cocaine addiction_Homo sapiens_hsa05030 | 0.14348425 |
153 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.14177618 |
154 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.13330616 |